Open Science Summit

Program 2011

Day I Saturday, Oct 22


8:15-8:45am 

 

 

 

 

8:45 - 9:45

Victoria StoddenKeynote: Transparency in Scientific Discovery: Implications for Innovation and Knowledge Dissemination

Abstract: Open Science is will be an inescapable part of scientific
research. As computation assumes a central role in the practice of
science, open science facilitates the reproducibility of published
computational findings, promotes innovation in academia and in
industry, and provides access to scientific knowledge beyond the ivorytower. In this talk I discuss the coming imperative of open science, and outline its implications for scientific integrity, the independent replication of results, the intellectual property framework for scientific knowledge, and public access to scientific knowledge

Open Access, where we are, where we are going.

 

Nick Shockey SPARC,
Jill Cirasella, CUNY
Margaret Smith, NYU

9:45 – 10:00 Break
10 am-11:45 am The Future (the End?) of “Intellectual Property”
Johanna Blakely: Ready to Share, Lesson’s from the fashion industry’s Free CultureStephan Kinsella: IP and the New Mercantilism
Andrew Torrance, Patents and Modern Biotechnology
Allen Black, The Fabyrzme Debacle, the Tragedy of Monopoly
11:45 – 1:00 Lunch
1:00 -3:00 This year in Open Science, Highlights from 2011Joyce Peng, Bejing Genomics Institute, Crowd-Sourcing the Scientific Response to the eColi OutbreakPeter Murray Rust

William Gunn (Mendeley)

Daniel Mietchen, Wikimedia and Open Science

Wikis are an invitation to collaborate. Science is an endeavour involving ever more collaboration across space and time. In this talk, we will take a look at the integration of wikis with scholarly workflows, paying special attention to Wikimedia projects.

 

Dave Toole Skolr poster session sharing software, DigitalOcean project

Anton Geraschenko, Math Overflow

Jai Rangathan, SciFund Challenge (Crowdfunding research)

Building an Open Science Business

Alex Hodgson, 1degreeBio

Carlo Rago, OpenOnward, WikiFormulation

Adam Regelman, Quartzy

Elizabeth Iorns, Sciencexchange

 

 

3:00- 3:15 Break
3:15-4:30 pm Science Communication: Conveying the possibility of radical longevity breakthroughs to the public Sonia Arrison, best selling author, 100+ Incentive Mechanisms for Collaborative Innovation
Jamie Love, Knowledge Ecology InternationalDavid Thompson, UCSF

 

4:45-5:45 pm Open Innovation and Appropriate Technology
Gerald Barnett, Open Source 3D printing
Bryan Bishop, CAD and Open Hardware
Rob Meagley, Bootstrapping low cost instruments
Akhsar Kharebov, Open Source robotics and hardware

Day II: Open Medicine, Open Genomics, Clinical Trials 2.0

8:30 – 10:00 Personal Genomics, Hype, Hope, or Both?Misha Angrist, the Personal Genome Project and patient empowermentRade Drmanac, co-founder Complete Genomics

David Ewing Duncan, Experimental Man, Personal Health Manifesto

Raymond McCauley, BioCurious, citizen science and really personal genomics

Jason Bobe, Personal Genome Project + Bioweathermaps

10:00 – 10:15 Break
10:15 – 12:00 Opening the Sources of Drug DiscoveryBernard MunosBarry Bunin (Collaborative Drug Discovery)

Matt Todd, Open Source chemistry for neglected diseases

David Shaywitz

Improved measurement: a path to better health for real people

12:00-1:00 Lunch

1:00-2:15 Open Education and the Future of Science Education Ingmar Riedel-Kruse and Rhiju Das, 

Biotechnology Games (EteRNA, Fold It, Biotic games/Pacman Paramecia)

 

Alex Peake Code Hero + Primer Labs

Mitch Altman, Noisebridge, Hacker Spaces and Education of the Future

 

 


 

2:15 – 2:30 Break
2:30- 3:30

Life Sciences in the era of Big Data

Andreas Sundquist, CEO DNAnexus Open Science and the SRA

Ilya Kupershmidt, co-founder Next Bio

 

Joel Dudley, Numedii, Data Driven drug Repurposing


 

 

 

3:30-3:45 Break
3:45-5:45 

 


Open Medicine and Clinical Trials 2.0 Tomasz Sablinksi, Founder, CEO, Transparency Life SciencesLorenzo Albanello, Open medical data to improve personalized medicine

Marty Tenenbaum, Cancer Commons

Lindy Avey, Curious

Collection of in-depth patient phenotypic data in basic and clinical research presents significant challenges and may partly be one of the gating factors in advancing the field of personalized healthcare. Using the web and social networking tools, a new research paradigm is emerging that incorporates higher levels of patient involvement (Research 2.0) enabling prospective, dynamic engagement with the ‘experts’. How will drug development, testing, and approval as well as comparative medicine be able to embrace this shift in protocol design for a more progressive approach?

Marissa Nelson, 23andMe

Nicole Boice, RARE Project, Global Genes Project, crowd-funding of rare diseases

 

 

 

2010 Conference Program